TB under the microscope

  • April 18, 2012
TB under the microscope

A new organisation will bring together experts on global health to tackle major diseases.

The chief medical officer of pharmaceutical giant GlaxoSmithKline will give the keynote address at a conference dedicated to finding new ways to tackle diseases which disproportionately affect developing countries.

The Cambridge Global Health Commercialization & Funding Roundtable has been organised by three Gates Cambridge scholars and two other students and takes place this Thursday and Friday.

Ellen Strahlmanfrom GlaxoSmithKline will give the keynote address on Thursday and Friday is reserved for a series of panel discussions on the theme of tuberculosis, including social entrepreneurship in TB delivery, global health funding and TB vaccines.

Among those taking part are Christopher Dye, Director of Health Information in the Office of HIV/AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases at the World Health Organization; Patrick Gihana-Mulenga, the Rwanda High Commission Commercial Attaché; Bina Rawal, Head of Clinical Development in the Technology Transfer Division of the Wellcome Trust; Davino Sena, Head of Science and Technology at the Embassy of Brazil in London; Shelly Batra, President of OperationASHA; Suresh Jadhav, Executive Director of the Serum Institute of India Ltd; and David Brown, Adviser of One World Health. Global experts in tackling health problems, including academics, funding and investment companies, biotechnology companies and vaccine manufacturers are also taking part.

Gates Cambridge scholar Julia Fan Li [2008] is the chairperson of the GHCF Roundtable. The organising team is Priya Khetarpal, Tomas Niklitschek and Gates Cambridge scholars Nicole Person-Rennell [2011] and Diana Pirjol [2011].

The Roundtable was set up to examine entrepreneurial activity in global health and to explore opportunities and business models to reconcile healthcare innovation and access. It brings together entrepreneurs, scientists, civil society, investors, funders, academics and ecosystem participants to explore business models in the discovery, development and delivery of global health innovations.

Its aims include sharing best practices of existing business models, stimulating new thinking upon the catalytic resource providers of both grant and investment-funding and encouraging awareness and public engagement on the issue of global health.

“We are really excited to be examining biomedical innovation from a holistic perspective.” says Julia Fan Li, “and pleased to welcome passionate global health experts from all over the world to Cambridge.”

For more information, click here.

Photo credit: Creative Commons, Ray Butler, CDC and Microbe World.

Latest News

Bridging the public health data gap

When Anwesha Lahiri  [2021] was doing her master’s fieldwork in India, she visited a tribal village in a remote area on top of a mountain between two districts. Only around 500 people lived there and there was no proper road leading to the village. At the heart of the problem was the dangerous ascent needed […]

Tracing the origins of our political beliefs

What makes some people more vulnerable to extremism than others? How do we build cognitive resilience against extreme ideologies? And how does the brain react to misinformation on social media? These are some of the key political questions that political neuroscientist Leor Zmigrod [2016] is exploring, putting the science into our understanding of radicalisation.   Leor […]

A leading woman in STEAM

A Gates Cambridge Scholar has been selected as one of the 75 leading women in Science, Technology, Engineering, Arts and Mathematics in India. Yama Dixit will feature in the second edition of the book She Is, published by the Red Dot Foundation in partnership with the Office of the Principal Scientific Adviser, Government of India to mark 75 […]

Tackling the obesity epidemic in Africa

When she left school, Paula-Peace James-Okoro [2022] intended to become a medical doctor, but after starting a degree in Biochemistry she discovered a passion for the subject and for using it to address one of the major health challenges facing Africa – obesity. She says: “In Africa, the rates of metabolic diseases, like obesity and […]